← Back to catalogue

Obesimed Forte 42 c

EUDAMED

Class IIa (EU MDR)

Ref 028958Ref 071770Ref 017594Ref 018508Ref 020952Ref 071657

by PK Benelux BV

Identity

Trade Name
Obesimed Forte 42 c EUDAMED
Device Name
Obesimed Forte EUDAMED
Model / Reference
028958 EUDAMED
071770 EUDAMED
017594 EUDAMED
018508 EUDAMED
020952 EUDAMED
071657 EUDAMED

Identifiers

Primary DI / UDI-DI
D-028958PH EUDAMED
D-071770P3 EUDAMED
D-017594NF EUDAMED
D-018508N3 EUDAMED
D-020952MD EUDAMED
D-071657P6 EUDAMED
Basic UDI-DI
B-028958PH EUDAMED
B-071770P3 EUDAMED
B-017594NF EUDAMED
B-018508N3 EUDAMED
B-020952MD EUDAMED
B-071657P6 EUDAMED
EMDN Code
G0402 ORALLY ADMINISTERED DEVICES FOR APPETITE CONTROL AND REDUCTION OF INTESTINAL ABSORPTION EUDAMED

Classification

Device Class
Class IIa EUDAMED
Market of Registration
Netherlands EUDAMED
Portugal EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Obesimed Forte 42 c by PK Benelux BV — Class IIa — MDD — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
PK Benelux BV
EUDAMED SRN
NL-MF-000006672

Sources (6)

  • EUDAMED 7aa15238-17bc-45af-815c-4347a41b719b 61 fields · synced Aug 2, 2026
  • EUDAMED bdd6327d-4e69-44d1-af1f-575528ccaf9a 61 fields · synced May 17, 2026
  • EUDAMED 7cefd998-d595-4244-97ab-055e0ca1e65b 61 fields · synced May 17, 2026
  • EUDAMED f675ffeb-892c-4536-97c5-4636e351aa4c 61 fields · synced May 18, 2026
  • EUDAMED b1f8d444-8b11-4fd7-b30f-5814b5afcf6c 61 fields · synced May 18, 2026
  • EUDAMED e6f67192-f01b-40e3-99d5-2d5e61dd28a8 61 fields · synced May 18, 2026